Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa

ObjectiveTo evaluate the efficacy of ceftazidime-avibactam (CZA) and aztreonam-avibactam (AZA) against bloodstream infections (BSIs) or lower respiratory tract infections (LRTIs) – caused by extensive drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa.MethodThe two-fold dilution m...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yixin Kang, Lu Xie, Jiyong Yang, Junchang Cui
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2023-06-01
Serie:	Frontiers in Cellular and Infection Microbiology
Soggetti:	extensively drug-resistant Pseudomonas aeruginosa pan drug-resistant Pseudomonas aeruginosa ceftazidime-avibactam 173 aztreonam-avibactam whole-genome sequencing
Accesso online:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1023948/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!